- Home
- LVTX vs MLSS Comparison
LVTX vs MLSS Comparison
Compare LVTX & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- MLSS
- Stock Information
- Founded
- LVTX 2016
- MLSS 1989
- Country
- LVTX Netherlands
- MLSS United States
- Employees
- LVTX N/A
- MLSS N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- LVTX Health Care
- MLSS Health Care
- Exchange
- LVTX Nasdaq
- MLSS Nasdaq
- Market Cap
- LVTX 40.0M
- MLSS 42.4M
- IPO Year
- LVTX 2021
- MLSS 1995
- Fundamental
- Price
- LVTX $1.58
- MLSS $0.48
- Analyst Decision
- LVTX Hold
- MLSS Buy
- Analyst Count
- LVTX 4
- MLSS 1
- Target Price
- LVTX $1.58
- MLSS $1.25
- AVG Volume (30 Days)
- LVTX 513.1K
- MLSS 211.1K
- Earning Date
- LVTX 12-09-2025
- MLSS 11-13-2025
- Dividend Yield
- LVTX N/A
- MLSS N/A
- EPS Growth
- LVTX N/A
- MLSS N/A
- EPS
- LVTX N/A
- MLSS N/A
- Revenue
- LVTX $4,990,000.00
- MLSS $9,083,205.00
- Revenue This Year
- LVTX N/A
- MLSS $16.06
- Revenue Next Year
- LVTX N/A
- MLSS $14.73
- P/E Ratio
- LVTX N/A
- MLSS N/A
- Revenue Growth
- LVTX N/A
- MLSS 7.84
- 52 Week Low
- LVTX $0.85
- MLSS $0.38
- 52 Week High
- LVTX $2.06
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- LVTX 53.29
- MLSS 50.93
- Support Level
- LVTX $1.58
- MLSS $0.41
- Resistance Level
- LVTX $1.63
- MLSS $0.46
- Average True Range (ATR)
- LVTX 0.06
- MLSS 0.04
- MACD
- LVTX 0.01
- MLSS 0.00
- Stochastic Oscillator
- LVTX 72.99
- MLSS 47.58
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.